Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


Disputed vax sent to TGA

Posted 25 February 2021 AM

MSD's has filed V114, a 15-valent pneumococcal conjugate vaccine which is the subject of an ongoing and hard-fought court battle against Pfizer, with the TGA.

MSD confirmed the filing, which the TGA describes as for pneumococcal vaccine containing the active ingredient pneumococcal purified capsular polysaccharides, is the 15-valent vaccine that Pfizer has alleged infringes its patent on Prevenar 13.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
All fine, nothing to see here
How politics made a mess of the rollout
Special Report
PBAC July Agenda
Committee to assess 36 submissions
Approvals Action
First copy of gout drug
Plus new formulations of PBS-listed drugs
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas